Article (Scientific journals)
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial
Kroiss, R.; Fentiman, I. S.; Helmond, F. A. et al.
2005In BJOG: An International Journal of Obstetrics and Gynaecology, 112 (2), p. 228-233
Peer Reviewed verified by ORBi
 

Files


Full Text
kroiss R BJOG 2005.pdf.pdf
Author postprint (188.49 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Objective To assess the effects of tibolone on climacteric symptoms, endometrium and serum lipid/lipoproteins in postmenopausal women receiving tamoxifen after surgery for breast cancer. Design Double-blind, randomised, placebo-controlled, multicentre pilot study. Setting Hospital outpatient clinic. Sample Seventy postmenopausal women receiving tamoxifen following surgery for early breast cancer. Methods Women received 20 mg/day oral tamoxifen plus either 2.5 mg/day oral tibolone or placebo for 12 months. Main outcome measures Frequency and severity of hot flushes (diary cards); intensity of hot flushes and sweats (Landgren scale); interference of hot flushes and sweats with normal life; frequency and intensity of other climacteric symptoms; endometrial thickness and histology; vaginal bleeding; breast cancer recurrence and serum lipid/lipoproteins. Results Daily card data showed no change in the daily number of hot flushes with either tibolone or placebo (P= 0.219) after three months. There was a significant reduction in the severity of flushes with tibolone compared with placebo (-0.4 vs 0.2, P= 0.031). The Landgren scale showed a mean change in the number of hot flushes of -0.6 with tibolone and +1.1 with placebo after 12 months (P= 0.022). Endometrial biopsies were normal and vaginal bleeding was similar in both groups. A significant decrease in triglycerides (-23%vs 1.4%) and HDL (-12%vs 19%) was seen with tibolone compared with placebo after 12 months. Conclusion Tibolone prevented an increase in hot flushes in postmenopausal women given tamoxifen following surgery for breast cancer without untoward effects on the endometrium. Beneficial effects on serum lipid profile were noted.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Kroiss, R.
Fentiman, I. S.
Helmond, F. A.
Rymer, J.
Foidart, Jean-Michel ;  Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Bundred, N.
Mol-Arts, M.
Kubista, E.
Language :
English
Title :
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial
Publication date :
February 2005
Journal title :
BJOG: An International Journal of Obstetrics and Gynaecology
ISSN :
1470-0328
eISSN :
1471-0528
Publisher :
Blackwell Publishing, Oxford, United Kingdom
Volume :
112
Issue :
2
Pages :
228-233
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 07 April 2009

Statistics


Number of views
74 (1 by ULiège)
Number of downloads
292 (0 by ULiège)

Scopus citations®
 
54
Scopus citations®
without self-citations
49
OpenCitations
 
43

Bibliography


Similar publications



Contact ORBi